Results 161 to 170 of about 179,020 (284)
ABSTRACT The therapeutic landscape of hepatocellular carcinoma (HCC) has been transformed by recent advancements in systemic therapies, particularly with the introduction of immune checkpoint inhibitors, expanding treatment options beyond conventional locoregional approaches.
Keiichi Akahoshi +4 more
wiley +1 more source
Correction to: Atypical Presentations of Levator Ani Syndrome With Perianal Hyperhidrosis: A Case Series. [PDF]
Gupta R +3 more
europepmc +1 more source
Annals of Gastroenterological Surgery, EarlyView.
Shyam Sundar Sah, Abhishek Kumbhalwar
wiley +1 more source
Correction: Biliary stents reshape the bile microbiome in the absence of cholangitis. [PDF]
Kayashima A +5 more
europepmc +1 more source
The prognostic value of the log odds of positive lymph nodes (LODDS) across BMI categories was investigated in patients undergoing colorectal cancer resection. The exploratory evidence demonstrates that LODDS serves as a strong prognostic marker, and its adverse effect may be more pronounced in patients with higher BMI.
Kazuhiro Taguchi +27 more
wiley +1 more source
Hepatology clinician readiness to provide addiction treatment in hepatology clinics: A mixed-methods formative evaluation. [PDF]
Haque LY +5 more
europepmc +1 more source
We evaluated whether anatomical resection (AR) provides an oncological benefit over non‐anatomical resection (NAR) in solitary hepatocellular carcinoma ≤ 5 cm without predicted microvascular invasion or intrahepatic metastasis, identified by preoperative DCP ≤ 150 mAU/mL.
Norifumi Iseda +6 more
wiley +1 more source

